Evidence map›Paper›PMID 25172294›Full record

ArticleEuropean journal of cancer (Oxford, England : 1990)2014

Oesophageal squamous cell carcinoma in high-risk Chinese populations: Possible role for vascular epithelial growth factor A.

Asieh Golozar, Terri H Beaty, Patti E Gravitt, Ingo Ruczinski, You-Lin Qiao, Jin-Hu Fan, Ti Ding, Ze-Zhong Tang, Arash Etemadi, Nan Hu and 8 more

Open access · greenAbstract read
In one paragraph

Article in European journal of cancer (Oxford, England : 1990), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Association of VEGF Gene Polymorphisms with the Risk and Prognosis of Cutaneous Squamous Cell Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2016
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Asieh GolozarDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: agolozar@jhu.edu.
Terri H BeatyDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Patti E GravittDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Ingo RuczinskiDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
You-Lin QiaoDepartment of Epidemiology, Cancer Institute (Hospital), Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Jin-Hu FanDepartment of Epidemiology, Cancer Institute (Hospital), Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Ti DingShanxi Cancer Hospital, Taiyuan, Shanxi, People's Republic of China.
Ze-Zhong TangShanxi Cancer Hospital, Taiyuan, Shanxi, People's Republic of China.
Arash EtemadiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Nan HuDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Paula L HylandDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Lemin WangDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Chaoyu WangDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Sanford M DawseyDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Neal D FreedmanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Christian C AbnetDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Alisa M GoldsteinDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Philip R TaylorDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Division of Cancer Epidemiology and GeneticsJohns Hopkins University · USNational Cancer Institute · USChinese Academy of Medical Sciences & Peking Union Medical College · CNShanxi Provincial Cancer Hospital · CN

Funding

Nutrition Intervention Trials in Linxian ChinaZIACP000112 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ABNET, CHRISTIAN · 2009 to 2025
$8.2M
Nutrition Intervention Trials in Linxian ChinaZ01CP000112 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI TAYLOR, PHILIP · 2005 to 2008
$2.0M
UGI Cancer Genetic StudiesZ01CP000150 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI TAYLOR, PHILIP · 2005 to 2008
$1.8M
Intramural NIH HHS Z01 CP000112Intramural NIH HHS Z01 CP000150
6 · The paper itself

Abstract

backgroundMechanisms involved in wound healing play some role in carcinogenesis in multiple organs, likely by creating a chronic inflammatory milieu. This study sought to assess the role of genetic markers in selected inflammation-related genes involved in wound healing (interleukin (IL)-1a, IL-1b, IL-1 Receptor type I (IL-1Ra), IL-1 Receptor type II (IL-1Rb), tumour necrosis factor (TNF)-α, tumour necrosis factor receptor superfamily member (TNFRSF)1A, nuclear factor kappa beta (NF-kB)1, NF-kB2, inducible nitric oxide synthase (iNOS), cyclooxygenase (COX)-2, hypoxia induced factor (HIF)-1α, vascular endothelial growth factor (VEGF)A and P-53) in risk to oesophageal squamous cell carcinoma (OSCC).

methodsWe genotyped 125 tag single nucleotide polymorphism (SNP)s in 410 cases and 377 age and sex matched disease-free individuals from Nutritional Intervention Trial (NIT) cohort, and 546 cases and 556 controls individually matched for age, sex and neighbourhood from Shanxi case-control study, both conducted in high-risk areas of north-central China (1985-2007). Cox proportional-hazard models and conditional logistic regression models were used for SNPs analyses for NIT and Shanxi, respectively. Fisher's inverse test statistics were used to obtain gene-level significance.

resultsMultiple SNPs were significantly associated with OSCC in both studies, however, none retained their significance after a conservative Bonferroni adjustment. Empiric p-values for tag SNPs in VEGFA in NIT were highly concentrated in the lower tail of the distribution, suggesting this gene may be influencing risk. Permutation tests confirmed the significance of this pattern. At the gene level, VEGFA yielded an empiric significance (P=0.027) in NIT. We also observed some evidence for interaction between environmental factors and some VEGFA tag SNPs.

conclusionOur finding adds further evidence for a potential role for markers in the VEGFA gene in the development and progression of early precancerous lesions of oesophagus.

Indexed as

Polymorphism, Single NucleotideAgedCarcinoma, Squamous CellCase-Control StudiesChinaCohort StudiesEsophageal NeoplasmsEsophagusFemaleGene Expression Regulation, NeoplasticGenotypeHumansInflammationMaleMiddle AgedProportional Hazards ModelsVascular Endothelial Growth Factor AVEGFA protein, humanGenetic markerGeneticsInflammationInflammation-related eventsOesophageal squamous cell carcinomaVascular endothelial growth factor AVEGFAWound-healing

Identifiers

PMID25172294
PMCPMC4363989
OpenAlexW2004911630

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.